| Date Filed | Type | Description |
| 08/10/2023 |
4
| Niederhuber John (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,571 restricted stock units
@ $0 |
|
| 08/10/2023 |
4
| Kunz Barbara Lopez (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,571 restricted stock units
@ $0 |
|
| 08/10/2023 |
4
| Harsanyi Zsolt (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,571 restricted stock units
@ $0 |
|
| 08/10/2023 |
4
| Grant Grady III (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,571 restricted stock units
@ $0 |
|
| 08/10/2023 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,571 restricted stock units
@ $0 |
|
| 08/10/2023 |
4
| Taylor Daphne (SVP, CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 6,945 restricted stock units
@ $0 |
|
| 08/10/2023 |
4
| Kwon SoYoung (SVP, GC, BD & Corp Affairs) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 9,375 restricted stock units
@ $0 |
|
| 08/10/2023 |
4
| Lamothe Jeffrey G. (EVP, COO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 11,979 restricted stock units
@ $0
Exercised 1,833 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Grant Grady III (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 297 restricted stock units
@ $0
Granted 3,571 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Kunz Barbara Lopez (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 297 restricted stock units
@ $0
Granted 3,571 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Niederhuber John (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 297 restricted stock units
@ $0
Granted 3,571 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 297 restricted stock units
@ $0
Granted 3,571 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Harsanyi Zsolt (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 297 restricted stock units
@ $0
Granted 3,571 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Kwon SoYoung (SVP, GC, BD & Corp Affairs) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 1,834 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Lamothe Jeffrey G. (EVP, COO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,666 restricted stock units
@ $0
Granted 16,500 restricted stock units
@ $0
Granted 16,500 options to buy
@ $2.15, valued at
$35.5k
|
|
| 03/07/2023 |
4
| Kwon SoYoung (SVP, GC, BD & Corp Affairs) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 3,666 restricted stock units
@ $0
Granted 11,000 restricted stock units
@ $0
Granted 11,000 options to buy
@ $2.15, valued at
$23.7k
|
|
| 03/07/2023 |
4
| Taylor Daphne (SVP, CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 11,000 options to buy
@ $2.15, valued at
$23.7k
Granted 11,000 restricted stock units
@ $0
Exercised 1,583 restricted stock units
@ $0 |
|
| 03/07/2023 |
4/A
| Abdun-Nabi Daniel (Director) has filed a Form 4 on Aptevo Therapeutics Inc. |
| 03/07/2023 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 9,582 restricted stock units
@ $0
Granted 38,750 restricted stock units
@ $0
Granted 38,750 options to buy
@ $2.15, valued at
$83.3k
|
|
| 03/07/2023 |
3
| Taylor Daphne (SVP, CFO) has filed a Form 3 on Aptevo Therapeutics Inc. |
| 01/30/2023 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 4,791 restricted stock units
@ $0 |
|
| 01/30/2023 |
4
| Lamothe Jeffrey G. (CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 1,834 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Grant Grady III (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 3,571 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Kunz Barbara Lopez (Director) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 3,571 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Lamothe Jeffrey G. (CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 5,500 restricted stock units
@ $0
Granted 5,500 options to buy
@ $4.32, valued at
$23.8k
Granted 23,958 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Lamothe Jeffrey G. (CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 11,000 options to buy
@ $0 |
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|